Pericardial effusion is a medical condition characterized by the abnormal buildup of fluid within the pericardial sac, a protective membrane enveloping the heart. This accumulation can arise from a diverse range of factors, including infectious agents, inflammatory disorders, traumatic injuries, or pre-existing health conditions. The presence of excess fluid in the pericardial sac exerts pressure on the heart, potentially impairing its normal functioning. Individuals with pericardial effusion may experience a spectrum of symptoms, with chest pain, shortness of breath, and fatigue being commonly reported. These symptoms can significantly impact a person's quality of life and may necessitate prompt medical attention. Diagnosis typically involves specialized imaging techniques such as echocardiography, enabling healthcare professionals to visualize the extent of fluid accumulation and assess its impact on cardiac function. The underlying cause of pericardial effusion guides the course of treatment. Management strategies may include addressing the root cause, such as treating infections or managing inflammatory conditions. In certain instances, medical interventions like drainage procedures or the administration of anti-inflammatory medications may be recommended to alleviate symptoms and prevent potential complications.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt